Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Colby S. Thaxton
Northwestern University at Chicago, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
AuraSense Therapeutics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The goal of this project is to develop highly innovative targeted therapeutics delivered by bio-inspired tailorable constructs conjugated to gold nanoparticles to prevent restenosis following vascular interventions in humans. Biomimetic high density lipoproteins used in this research are licensed to AuraSense, LLC, an entity in which the investigator discloses significant financial interests in the form of equity interests. AuraSense Therapeutics, LLC, is a related entity in which the investigator discloses significant financial interests in the form of equity interests and remuneration.
Novel Vehicles for Targeted Cardiovascular Repair
The overall goal of this Bioengineering Research Partnership is to develop highly innovative targeted therapeutics to prevent restenosis following vascular interventions. Given that atherosclerosis is a leading cause of death and disability in the USA, and the high incidence of restenosis following cardiovascular interventions, this novel translational research has the potential to impact millions of people, and thus has tremendous relevance to public health.
Filed on November 11, 2013.
Tell us what you know about Colby S. Thaxton's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Colby S. Thaxton”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Colby S. Thaxton | Northwestern University at Chicago | Conflict of Interest | Aurasense, LLC | Value cannot be readily determined |
| Colby S. Thaxton | Northwestern University at Chicago | Conflict of Interest | AuraSense, LLC | Value cannot be readily determined |
| Colby S. Thaxton | Northwestern University at Chicago | Conflict of Interest | AuraSense Therapeutics, LLC | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.